KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Royalty Pharma (RPRX) Goodwill & Intangibles (2019 - 2025)

Historic Goodwill & Intangibles for Royalty Pharma (RPRX) over the last 4 years, with Q4 2025 value amounting to $924.6 million.

  • Royalty Pharma's Goodwill & Intangibles changed N/A to $924.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $924.6 million, marking a year-over-year change of. This contributed to the annual value of $924.6 million for FY2025, which is N/A changed from last year.
  • As of Q4 2025, Royalty Pharma's Goodwill & Intangibles stood at $924.6 million.
  • Royalty Pharma's 5-year Goodwill & Intangibles high stood at $924.6 million for Q2 2025, and its period low was $5.7 million during Q4 2021.